Sensei Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designe…

Biotechnology
US, Rockville [HQ]

Lobbying Analysis

Sensei Biotherapeutics, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of SNSE's Analysis
CIK: 1829802 CUSIP: 81728A108 ISIN: US81728A1088 LEI: - UEI: -
Secondary Listings
SNSE has no secondary listings inside our databases.